Hi eddy, I do remember reading that some participants have been taking ATC for up to 2 years now. So, I would imagine they would have a good indication by now of its lack of adverse side effects.
It is quite possible with positive 24 week, phase 3 data(instead of usual 48 wk), they can get accelerated approval.
Time will tell and for now I feel when the current results are published, interested parties will have something to go on. That for me will be the big news.
AVX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
